Hypothesis: Set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 5-6, 2005, Pages 384-393

  Osborn, John W ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Hypertension; Renal function curve; Set point; Sympathetic nervous system

Indexed keywords

ARTERIAL PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; BODY FLUID; BRAIN; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; HEART OUTPUT; KIDNEY; KIDNEY FUNCTION; KIDNEY PERFUSION; MEAN ARTERIAL PRESSURE; PRESSORECEPTOR REFLEX; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; BRAIN; HUMANS; KIDNEY; MODELS, CARDIOVASCULAR; NEURAL PATHWAYS; TIME;

EID: 20344363213     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04200.x     Document Type: Conference Paper

References (73)

1. Fink GD. Hypothesis: The systemic circulation as a regulated free-market economy. A new approach for understanding the long-term control of blood pressure. Clin. Exp. Pharmacol. Physiol. 2005; 32: 377-83.
2. Guyton AC, Coleman TG, Cowley Jr AW, Manning Jr RD, Norman Jr RA, Ferguson JD. A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ. Res. 1974; 35: 159-69.
3. Guyton AC. Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am. J. Hypertens. 1989; 2: 575-85.
4. Guyton AC. Renal function curves and control of body fluids and arterial pressure. Acta Physiol. Scand. 1990; 139 (Suppl. 591): 107-13.
5. Guyton AC, Coleman TG, Cowley Jr AW. Scheel KW, Manning Jr RD, Norman Jr RA. Arterial pressure regulation: Overriding dominance of the kidneys in long-term regulation and in hypertension. Am. J. Med. 1972; 52: 584-94.
6. Guyton AC. Circulatory Physiology III: Arterial Pressure and Hypertension. WB Saunders, Philadephia. 1980.
7. Roman RJ, Cowley Jr AW. Characterization of a new model for the study of pressure-natriuresis in the rat. Am. J. Physiol. 1985; 248: F190-8.
8. Cowley Jr AW, Skelton MM, Papanek PE, Greene AS. Hypertension induced by high salt intake in absence of volume retention in reduced renal mass rats. Am. J. Physiol. Heart Circ. Physiol, 1994; 267: H1707-12.
9. Fink GD, Johnson RJ, Galligan JJ. Mechanisms of increased venous smooth muscle tone in deoxycorticosterone acetate-salt hypertension. Hypertension 2000; 35: 464-9.
10. Julius S, Nesbitt S. Sympathetic overactivity in hypertension: A moving target. Am. J. Hypertens. 1996; 9: 113s-20s.
11. Greene AS, Yu ZY, Roman RJ, Cowley Jr AW. Role of blood volume expansion in Dahl rat model of hypertension. Am. J. Physiol. 1990; 258: H508-14.
12. Krieger JE, Liard J-F, Cowley Jr AW. Hemodynamics, fluid volume, and hormonal responses to chronic high-salt intake in dogs. Am. J. Physiol. Heart Circ. Physiol. 1990; 259: H1629-36.
13. Sullivan JM, Ratts TE. Hemodynamic mechanisms of adaptation to chronic high sodium intake in humans. Hypertension 1983; 5: 814-20.
14. Sullivan JM, Ratts TE. Sodium sensitivity in human subjects: Hemodynamic and hormonal correlates. Hypertension 1988; 11: 717-23.
15. Andresen MC, Yang M. Arterial baroreceptor resetting: Contributions of chronic and acute processes. Clin. Exp. Pharmacol. Physiol. 1989; 15 (Suppl.): 19-30.
16. McCubbin JW, Green JH, Page IH. Baroreceptor function in chronic renal hypertension. Circ. Res. 1956; 4: 205-10.
17. Cowley Jr AW, DeClue JW. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs. Circ. Res. 1976; 39: 779-87.
18. Cowley Jr AW, Liard JF, Guyton AC. Role of the baroreceptor reflex in daily control of arterial blood pressure and other variable in dogs. Circ. Res. 1973; 32: 564-76.
19. Cowley Jr AW, Quillen EW, Barber BJ. Further evidence for lack of baroreceptor control of long-term level of arterial pressure. In: Sleight P (ed.). Arterial Baroreceptors and Hypertension. Oxford University Press, New York. 1980; 391-9.
20. Osborn JW. Pathogenesis of hypertension in the baroreceptor-denervated spontaneously hypertensive rat. Hypertension 1991; 18: 475-82.
21. Osborn JW, Jacob F, Guzman P. A neural set point for the long-term control of arterial pressure: Beyond the baroreceptor reflex. Am. J. Physiol. 2005; 288 (available online: doi:10.11752/ajpregu. 00474.2004).
22. Barres C, Lewis SJ, Jacob HJ, Biody MJ. Arterial pressure lability and renal sympathetic nerve activity are dissociated in SAD rats. Am. J. Physiol 1992; 263: R639-46.
23. Iirgoyen MC, Moreira ED, Ida F, Pires M, Cestari IA, Krieger EM. Changes of renal sympathetic activity in acute and chronic conscious sinoaortic denervated rats. Hypertension 1995; 26: 1111-16.
24. Osborn JW, England SK. Normalization of arterial pressure after barodenervation: Role of pressure natriuresis. Am. J. Physiol. 1990; 259: R1172-80.
25. Sullivan JM, Prewitt RL, Ratts TE, Josephs JA, Connor MJ. Hemodynamic characteristics of sodium sensitive human subjects. Hypertension 1987; 9: 398-406.
26. Berecek KH, Murray RD, Gross F. Significance of sodium, sympathetic innervation, and central adrenergic structures on renal vascular responsiveness in DOCA-treated rats. Circ. Res. 1980; 47: 675-83.
27. Clarke D, Smookler HH, Barry H. Sympathetic nerve function and DOCA-NaCI induced hypertension. Life Sci 1970; 9: 1097-108.
28. Matsuguchi H, Schmid P. Pressor response to vasopressin and impaired baroreflex-function in DOC-salt hypetension. Am. J. Physiol. 1982; 242: H44-9.
29. Takeda K, Bunag RD. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats. Hypertension 1980; 2: 97-101.
30. Miller II AW, Bohr DF, Schork AM, Terris JM. Hemodynamic responses to DOCA in young pigs. Hypertension 1979; 1: 591-7.
31. Bravo E, Tarazi R, Dustan H. Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs. Circ. Res. 1977: 40 (Suppl. I): 1-140 (Abstract).
32. Conway J, Hatton J. Development of deoitycorticosterone acetate hypertension in the dog. Circ. Res. 1966; 43 (Suppl. 1): 1-82.
33. 1-adrenoceptor activity. Clin. Exp. Pharmacol. Physiol. 2005; 32: 254-61.
34. Bohr DF. What makes the pressure go up? A hypothesis. Hypertension 1981; 3: 11 106-65.
35. Brody MJ, Fink GD. Buggy J, Haywood JR, Gordon FJ, Johnson AK. The role of the anteroventral third ventricle (AV3V) region in experimental hypertension. Circ. Res. 1978; 43 (Suppl. I): I-2-13.
36. Buggy J, Fink GD, Johnson AK, Brody MJ. Prevention of the development of renal hypertension by anteroventral third ventricular tissure lesions. Circ. Res. 1977; 40 (Suppl. I): 1-110-17.
37. Songu-Mize E, Sealer SL, Caldwell RW. Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity. Hypertension 1982; 4: 575-80.
38. Johnson AK, Loewy AD. Circumventricular organs and their role in visceral functions. In: Loewy AD, Spyer KM (eds). Central Regulation of Autonomivunctions. Oxford University Press. New York. 1990; 247-67.
39. McKinley MJ, Johnson AK. The physiological regulation of thirst and fluid intake. News Physiol. Sci. 2004; 19: 1-6.
40. McKinley MJ, McAllen RM, Davern P et al. The Sensory Circumventricular Organs of the Mammalian Brain. Springer, Berlin. 2003.
41. Johnson AK, Gross PM. Sensory Circumventricular organs and brain homeostatic pathways. FASEB J. 1993; 7: 678-86.
42. Alien AM. Blockade of angiotensin ATi-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge. J. Renin Angiotensin Aldosterone Syst. 2001; 2 (Suppl. 1): S120-4.
43. Allen AM, Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension 2002; 39: 275-80.
44. 1 receptors support blood pressure in hypertensive rats. Hypertension 2002; 40: 552-9.
45. Ferguson AV. Paraventricular nucleus neurons projecting to the dorsomedial medulla are influenced by systemic angiotensin II. Brain Res. Bull. 1988; 20: 197-201.
46. Ferguson AV, Bains JS. Angiotensin actions in subfornical organ and area postrema: Implications for long-term control of autonomic output. Clin. Exp. Pharmacol. Physiol. 1997; 24: 96-101.
47. Lahiri S. Physiological responses: Peripheral chemoreceptors and chemoreflexes. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds). The Lung: Scientific Foundations. Lippincott-Raven, Philadephia. 1997; 1747-56.
48. Cherniack NS, Altose MD. Central chemoreceptors. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds). The Lung: Scientific Foundations. Lippincott-Raven, Philadelphia. 1997; 1767-76.
49. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypetension: Role of rostral ventrolateral medulla. Curr. Hypertens. Rep. 2003; 5: 262-8.
50. Morimoto S, Sasaki S, Miki S et al. Presser response to pulsatile compression of the rostral ventolateral medulla mediated by nitric oxide and c-fos expression. Br. J. Pharmacol. 2000; 129: 859-64.
51. Morimoto S, Sasaki S, Miki S et al. Presser response to compression of the ventrolateral medulla mediated by glutamate receptors. Hypertension 1999; 33: 1207-13.
52. Morimoto S, Sasaki S, Takeda K et al. Decreases in blood pressure and sympathetic nerve activity by microvascular decompression of the rostral ventrolateral medulla in essential hypertension. Stroke 1999; 30: 1707-10.
53. Smith PA, Meaney J, Graham L et al. Relationship of neurovascular compression to central sympathetic discharge in essential hypertension. J. Am. Coll. Cardiol. 2004; 43: 1453-8.
54. Thrasher TH. Baroreceptors and the long-term control of blood pressure. Exp. Physiol. 2004; 89: 331-41.
55. Hashimoto K, Tanaka S, Hirata M, Chiba S. Response of the sinoatrial node to change in pressure in the sinus node artery. Circ. Res. 1967; XXI: 297-304.
56. Musgrave GE. Bimodal relationship between sinus node arterial distension and sinus node automaticity. Am. J. Physiol. 1981; 241: H311-16.
57. Loeb JM, deTarnowsky JM, Doerschuk SH, Whitson CC. Autoregulation of cardiac cycle length: Role of catecholamines. J. Pharmacol Exp. Ther. 1984; 231: 281-5.
58. Slovut D, Wenstrom J, Moeckel R, Salerno C, Park S, Osborn J. Beat-to-beat modulation of heart rate is coupled to coronary perfusion pressure in the isolated heart. J. Appl. Physiol. 1999; 86: 694-700.
59. Slovut DP, Wenstrom IC, Moeckel RB, Wilson RF, Osborn JW, Abrams JH. Respiratory sinus arrhythmia persists in transplanted human hearts following autonomie blockade. Clin. Exp. Pharmacol. Physiol. 1998; 25: 322-30.
60. Guyenet PG. Role of the ventral medulla oblongata in blood pressure regulation. In: Loewy AD, Spyer KM (eds). Central Regulation of Autonomie Functions. Oxford University Press, New York. 1990; 145-67.
61. Ehmke H, Persson P, Kircheim H. Pressure-dependent renin release: The kidney factor in long-term control of arterial pressure in conscious dogs. Clin. Exp. Theory Practice 1987; A9 (Suppl. 1): 181-95.
62. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31: 68-72.
63. Esler M. The sympathetic system and hypertension. Am. J. Hypertens. 2000; 13: 995-1055.
64. Greenwood JP, Stoker JB, Mary D. Single unit sympathetic discharge: Quantitative assessment in human hypertensive disease. Circ. Res. 1999; 100: 1305-10.
65. Mary D. The activity of single vasoconstrictor nerve units in hypertension. Acta Physiol. Scand. 2003; 177: 367-76.
66. Johansson M, Elam M, Rundquist B et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99: 2537-42.
67. Grassi G, Esler M. The sympathetic nervous system in renovascular hypertension: Lead actor or bit player? J. Hypertens. 2002; 20: 1071-3.
68. Mathias CJ. Role of sympathetic efferent nerves in blood pressure regulation and in hypertension. Hypertension 1991; 18 (Suppl. 5): 11122-30.
69. Tuncel M, Augustyniak R, Zhang W, Toto RD, Victor RG. Sympathetic nervous system function in renal hypertension. Curr. Hypertens. Rep. 2002; 4: 229-36.
70. Johansson M, Elam M, Rundquist B et al. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension. Hypertension 2000; 36: 543-8.
71. Struck J, Muck P, Trubger D et al. Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J. Hypertens. 2002; 20: 1143-9.
72. Fink GD. Long-term sympathoexcitatory effect of angiotensin II: A mechanism of spontaneous and renovascular hypertension. Clin. Exp. Pharmacol. Physiol. 1997; 24: 91-5.
73. Cowley Jr AW, Mattson DL, Lu S, Roman RJ. The renal medulla and hypertension. Hypertension 1995; 25: 663-73.